20
Participants
Start Date
October 23, 2019
Primary Completion Date
June 20, 2023
Study Completion Date
June 20, 2023
Hypofractionated radiotherapy
Resectable or marginally resectable tumors: preoperative hypofractionated 12x 3 Gy radiotherapy (4 days in a week, three weeks) prescribed on planned target volume (tumor volume + elective margins + setup/error margin) with daily image guidance with cone beam-CT or kV-portal position verification.
Hyperthermia
Deep hyperthermia (Celsius TCS or BSD-2000) according to local protocol combined with radiotherapy, twice a week.
Hypofractionated radiotherapy with boost
"Non-resectable/inoperable tumors: definitive hypofractionated 12x 3 Gy radiotherapy prescribed on planned target volume (tumor volume + elective margins + setup/error margin) with simultaneous integrated boost 3.5 Gy per fraction prescribed on boost planned target volume (tumor volume + setup/error margin), 4 days in a week, three weeks.~Radiotherapy with daily image guidance with cone beam-CT or kV-portal position verification."
The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw
Maria Sklodowska-Curie National Research Institute of Oncology
OTHER